Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AEye (LIDR) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for AEye (LIDR) over the last 5 years, with Q2 2025 value amounting to $2000.0.

  • AEye's Asset Writedowns and Impairment changed N/A to $2000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2000.0, marking a year-over-year decrease of 9997.99%. This contributed to the annual value of $35000.0 for FY2024, which is 9964.96% down from last year.
  • Latest data reveals that AEye reported Asset Writedowns and Impairment of $2000.0 as of Q2 2025.
  • AEye's 5-year Asset Writedowns and Impairment high stood at $9.9 million for Q4 2023, and its period low was $2000.0 during Q2 2025.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $153500.0 (2022), whereas its average is $1.5 million.
  • Per our database at Business Quant, AEye's Asset Writedowns and Impairment surged by 994141.41% in 2023 and then crashed by 9326.92% in 2024.
  • Over the past 5 years, AEye's Asset Writedowns and Impairment (Quarter) stood at $1.2 million in 2021, then tumbled by 91.77% to $99000.0 in 2022, then skyrocketed by 9941.41% to $9.9 million in 2023, then tumbled by 99.86% to $14000.0 in 2024, then plummeted by 85.71% to $2000.0 in 2025.
  • Its Asset Writedowns and Impairment was $2000.0 in Q2 2025, compared to $14000.0 in Q1 2024 and $9.9 million in Q4 2023.